Offered support for correcting many of the missteps in CDC’s original 2016 guidance and recognizing that a “one-size-fits-all” approach to pain management is not feasible.
Urged the administration to continue the transparency, flexibility, and inclusion to create a holistic, comprehensive, and multi-faceted approach to address the opioid epidemic that balances preventing the diversion and abuse of opioids with ensuring clinically appropriate care.
